top of page
Search

🩸The SWIFT trial - Whole Blood is not dead - With Prof Green and Prof Barnard



🎉 Exciting News! 🎉


We are thrilled to be the FIRST podcast to host the brilliant minds behind the groundbreaking SWIFT trial! 


Join us as we dive deep with Professor Laura Green and Professor Ed Barnard, the authors of this ground breaking study on pre-hospital whole blood use. 🚑💉



Blood products are evolving—and a groundbreaking trial published in the New England Journal of Medicine is shifting the pre-hospital trauma care landscape. If you've ever wondered whether whole blood transfusions outperform standard component therapy in real emergencies, this episode is your inside look. Join top UK experts, Professor Laura Green and Prof Ed Barnard, as they unravel the secrets behind the SWIFT trial—the first of its kind evaluating pre-hospital whole blood use for bleeding trauma patients. 


Discover how logistics, safety, and clinical outcomes come together in this game-changing research, and why it could redefine trauma response worldwide.In this episode, you'll discover the intricate setup of the SWIFT trial, involving over 900 trauma patients across UK air ambulances, and why logistical challenges like blood transport and storage are just as critical as the clinical questions. Laura and Ed share their behind-the-scenes insights into the rapid deployment of a national trial, the importance of stakeholder collaboration, and the surprising findings that whole blood is, at best, non-inferior—not superior—to standard care. 


We break down the core outcomes: mortality, massive transfusion, and how logistics like response times impact survival—plus, what this means for future trauma protocols. Stay tuned for the upcoming health economic evaluations and implementation insights from the trial—crucial for decision-makers considering adopting whole blood in their systems. 


Whether you're a pre-hospital clinician, trauma researcher, or health policy enthusiast, this episode arms you with the knowledge to understand the nuances of blood transfusion strategies in the most critical moments. As the first trial to explore whole blood use at this scale, the SWIFT study underscores that, while whole blood isn't a silver bullet, it offers logistical and safety advantages worth exploring further. With longer pre-hospital times in the UK and innovative transport solutions, this research opens new doors—potentially improving outcomes in remote or complex settings worldwide. Stay curious, because the story of whole blood in trauma is far from over—and the lessons from SWIFT will shape trauma care for years to come.


Perfect for trauma clinicians, emergency responders, and health systems planners eager to understand the future of blood transfusion in pre-hospital care—this episode is your essential briefing on cutting-edge trauma research.


 
 
 

Comments

bottom of page